Roth Conference Archives - Page 92 of 117

TuesdayMar 14, 2017 3:30 pm

Compass Diversified Holdings LLC (NYSE: CODI) Starts Presentation at 29th Annual ROTH Conference

Compass Diversified Holdings (NYSE: CODI) is a private equity firm specializing in acquisitions, buyouts, and middle market investments in North America. The company maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long term cash flow generation and value. Compass provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility and utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the company and to make cash distributions to its shareholders. For more information, visit the company’s website www.compassdiversifiedholdings.com. About NetworkNewsWire…

TuesdayMar 14, 2017 3:30 pm

Tower Semiconductor Ltd. (NASDAQ: TSEM) Starts Presentation at 29th Annual Roth Conference

Tower Semiconductor (NASDAQ: TSEM) is an independent semiconductor foundry that manufactures analog intensive mixed-signal semiconductor devices in the United States, Asia and Europe. The company provides various customizable process technologies, including SiGe, BiCMOS, mixed-signal/CMOS, radio frequency CMOS, CMOS image sensor, integrated power management, and micro-electro-mechanical systems. It also offers transfer optimization and development process services to integrated device manufacturers and fabless companies. The company serves various markets, such as consumer, automotive, medical, industrial and aerospace and defense. Tower Semiconductor Ltd. was founded in 1993 and is headquartered in Migdal Haemek, Israel. For more information, visit the company’s website at www.towersemi.com.…

TuesdayMar 14, 2017 3:30 pm

TG Therapeutics, Inc. (NASDAQ: TGTX) Starts Presentation at 29th Annual Roth Conference

TG Therapeutics (NASDAQ: TGTX) is a biopharmaceutical company that focuses on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. The company develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets an epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. For more information, visit the company’s website at www.tgtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

TuesdayMar 14, 2017 3:30 pm

Auris Medical Holding AG (NASDAQ: EARS) Starts Presentation at 29th Annual ROTH Conference

Auris Medical (NASDAQ: EARS) is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The company is focused on the phase 3 development of treatments for acute inner ear hearing loss (AM-111) and for acute inner ear tinnitus (Keyzilen®; AM-101) by way of intratympanic administration with biocompatible gel formulations. In addition, Auris Medical is pursuing intranasal betahistine for Meniere's disease and vestibular vertigo (AM-125) and early-stage research and development projects. The company was founded in 2003 and is headquartered in Zug, Switzerland. For more information, visit the company’s website at www.aurismedical.com. About NetworkNewsWire…

TuesdayMar 14, 2017 3:00 pm

Zafgen, Inc. (NASDAQ: ZFGN) Starts Presentation at 29th Annual Roth Conference

Zafgen (NASDAQ: ZFGN) is a biopharmaceutical company focused on developing therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate is the Beloranib, an injection, which is in phase III clinical trials for the treatment of obesity and hyperphagia in patients with Prader-Willi syndrome; that has completed phase II clinical trials to treat hypothalamic injury-associated obesity, including craniopharyngioma-associated obesity; and which has completed phase IIb clinical trials for the treatment of severe obesity in the general population. The company is also developing ZGN-839, a liver-targeted methionine aminopeptidase 2 (MetAP2) inhibitor that is in pre-clinical studies for the…

TuesdayMar 14, 2017 3:00 pm

Aptose Biosciences, Inc. (NASDAQ: APTO) Starts Presentation at 29th Annual ROTH Conference

Aptose Biosciences (NASDAQ: APTO) is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer research coupled with companion diagnostics to identify the optimal patient population for its products. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For more information, visit the company’s website at www.aptose.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

TuesdayMar 14, 2017 3:00 pm

Aqua Metals, Inc. (NASDAQ: AQMS) Starts Presentation at 29th Annual ROTH Conference

Aqua Metals (NASDAQ: AQMS) is engaged in reinventing lead recycling with its patent-pending AquaRefiningTM technology. Unlike smelting, AquaRefining is a room temperature, water-based process that is fundamentally non-polluting. Aqua Metals expects its modular AquaRefining systems to allow the lead-acid battery industry to simultaneously reduce negative environmental impacts and increase production to meet rapidly growing demand. Aqua Metals is based in Alameda, California and built its first recycling facility in Nevada’s Tahoe-Reno Industrial Center. For more information, visit the company’s website at www.aquametals.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication…

TuesdayMar 14, 2017 3:00 pm

Stamps.com, Inc. (NASDAQ: STMP) Starts Presentation at 29th Annual Roth Conference

Stamps.com (NASDAQ: STMP) provides Internet-based postage solutions in the United States. It offers solutions for mailing and shipping various mail pieces, such as postcards, envelopes, flats and packages using a range of United States Postal Service (USPS) mail classes, including First Class Mail, Priority Mail, Priority Mail Express, Media Mail, Parcel Select and others. The company’s products and services comprise USPS approved PC Postage service that enables users to print electronic stamps directly onto envelopes, plain paper, or labels using personal computer, printer and Internet connection. For more information, visit the company’s website at www.stamps.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

TuesdayMar 14, 2017 3:00 pm

PDL BioPharma Inc. (NASDAQ: PDLI) Starts Presentation at 29th Annual Roth Conference

PDL BioPharma (NASDAQ: PDLI) is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. The company offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. PDL BioPharma, Inc. has license agreements with various biotechnology and pharmaceutical companies, as well as acquires royalty and other assets. For more information, visit the company’s website at www.pdl.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of…

TuesdayMar 14, 2017 3:00 pm

Superior Drilling Products, Inc. (NYSE: SDPI) Starts Presentation at 29th Annual Roth Conference

Superior Drilling Products (NYSE: SDPI) is a drilling and completion tool technology company that manufactures, repairs, sells and rents drilling tools in the United States and internationally. It is involved in the design and manufacture of new drill bit and horizontal drill string enhancement tools for the oil, natural gas, and mining services industries; and the refurbishment of polycrystalline diamond compact drill bits. The company’s horizontal drilling tools include Drill N Ream, a well bore conditioning tool; Strider, a drill string oscillation system; V-Stream, an advanced conditioning system; and Dedicated Reamer Stinger that is used to enhance dedicated reamer operations.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Roth Conference

Compass Diversified Holdings LLC (NYSE: CODI) Starts Presentation at 29th Annual ROTH Conference

Tower Semiconductor Ltd. (NASDAQ: TSEM) Starts Presentation at 29th Annual Roth Conference

TG Therapeutics, Inc. (NASDAQ: TGTX) Starts Presentation at 29th Annual Roth Conference

Auris Medical Holding AG (NASDAQ: EARS) Starts Presentation at 29th Annual ROTH Conference

Zafgen, Inc. (NASDAQ: ZFGN) Starts Presentation at 29th Annual Roth Conference

Aptose Biosciences, Inc. (NASDAQ: APTO) Starts Presentation at 29th Annual ROTH Conference

Aqua Metals, Inc. (NASDAQ: AQMS) Starts Presentation at 29th Annual ROTH Conference

Stamps.com, Inc. (NASDAQ: STMP) Starts Presentation at 29th Annual Roth Conference

PDL BioPharma Inc. (NASDAQ: PDLI) Starts Presentation at 29th Annual Roth Conference

Superior Drilling Products, Inc. (NYSE: SDPI) Starts Presentation at 29th Annual Roth Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search